Franck Grall, PharmD, Ph.D.

Franck leads the BioAgilytix Boston lab with a dedication to innovative bioanalytical testing and on-time delivery of regulatory-compliant data. Franck also oversees client engagement and satisfaction and manages the day-to-day operations of the business and facility.

Franck is a highly skilled scientist with nearly three decades of professional experience. His areas of scientific expertise include immunogenicity, biomarkers, cell-based assays, toxicology, and in-vitro GLP testing of pharmaceuticals and medical devices. For nearly nine years (1998 to 2007), he was an instructor and researcher at the Harvard Medical School teaching hospital, Beth Israel Deaconess Medical Center in Boston, investigating novel biomarkers and gene regulation.

Prior to joining BioAgilytix in 2019, Franck directed the scientific services and research efforts at Cambridge Biomedical and Toxikon Corporation. He earned his doctoral degrees in Pharmacy and in Molecular Biology at the Paris-Sud University in France.